Current Edition


Topeka man involved in Alzheimer’s clinical trial

About 5 years ago, Topeka man, Allen Davis started to experience symptoms of Alzheimer’s Disease and Dementia. Now he’s focused on one thing. “Hopefully it’s not getting …

Continue Reading →

Feedback from Parkinson’s Patients Can Help Improve Trial Recruitment, Retention, Study Says

Getting the perspective of Parkinson’s disease patients on their motivations and experiences participating in clinical trials can help increase recruitment and retention of future studies, …

Continue Reading →

MediciNova Announces Full Enrollment in ALS Biomarker Clinical Trial

MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number:4875), today announced …

Continue Reading →

First-of-its-kind clinical trial will use reprogrammed adult stem cells to treat Parkinson’s

Researchers in Japan today announced the launch of a clinical trial to treat Parkinson’s disease with neurological material derived from induced pluripotent stem (iPS) cells, …

Continue Reading →

Marken Opens Clinical Trial Logistics Hub In Melbourne, Australia

Marken announced today the opening of a new branch located in Melbourne. The new location joins Sydney and Brisbane as the third Australian hub and …

Continue Reading →

Immunotherapy Clinical Trial Aims for Mesothelioma Cure

Medical oncologist Dr. Bernardo Goulart at the Seattle Cancer Care Alliance (SCCA) believes his latest clinical trial might be the most curative approach to treatment …

Continue Reading →

NIH-funded researchers present preliminary clinical trial results suggesting aggressive blood pressure control may lower risk of cognitive impairment

What Preliminary findings from a large clinical trial, the Systolic Blood Pressure Intervention Trial (SPRINT) Memory and Cognition IN Decreased Hypertension (SPRINT MIND) study will …

Continue Reading →
Asia Pacific

Korea’s ViroMed acquires DNA-producing facility for clinical trial in U.S.

ViroMed, a Korean developer of biologic drugs, Wednesday announced it has acquired a DNA production facility in San Diego, California, adding a manufacturing function to …

Continue Reading →

Altasciences Participates in Clinical Trial for Type 1 Diabetes Mellitus

Altasciences is pleased to have partnered with Xeris Pharmaceuticals, a specialty pharmaceutical company leveraging its novel formulation technology platforms to develop and commercialize ready-to-use, liquid-stable …

Continue Reading →

CStone’s PD-1 inhibitor CS1003 gets clinical trial approval in China

CStone will initiate a multi-center Phase I clinical trial to assess the safety, tolerability and preliminary anti-tumor activity of CS1003 in Chinese patients with advanced …

Continue Reading →